Insider Transactions in Q4 2020 at Champions Oncology, Inc. (CSBR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Philip P. Breitfeld Director |
SELL
Open market or private sale
|
Direct |
31,443
-100.0%
|
$345,873
$11.35 P/Share
|
|
Oct 30
2020
|
Scott R Tobin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$50,000
$5.46 P/Share
|
|
Oct 16
2020
|
David Sidransky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,100
-1.33%
|
$90,900
$9.01 P/Share
|
|
Oct 16
2020
|
David Sidransky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+2.15%
|
$83,335
$5.46 P/Share
|